Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

EACR 2016

9 - 12 Jul 2016
Manchester Central Convention Complex, Manchester, United Kingdom
miRNA screening through nipple aspiration sampling
Dr Cathy Moelans - University Medical Center Utrecht, Utrecht, Netherlands
miRNA screening through nipple aspiration sampling ( Dr Cathy Moelans - University Medical Center Utrecht, Utrecht, Netherlands )
26 Jul 2016
Towards deciphering the functional genetics and neo-antigenic landscape in melan...
Prof Yardena Samuels - Weizmann Institute of Science, Rehovot, Israel
Towards deciphering the functional genetics and neo-antigenic landscape in melanoma ( Prof Yardena Samuels - Weizmann Institute of Science, Rehovot, Israel )
18 Jul 2016
Polycomb repressors and epigenetic therapy
Dr Maarten van Lohuizen - Netherlands Cancer Institute, Netherlands, UK
Polycomb repressors and epigenetic therapy ( Dr Maarten van Lohuizen - Netherlands Cancer Institute, Netherlands, UK )
15 Jul 2016
DNA repair and mutations as targets for personalised therapy
Prof Zoltan Szallasi - Boston Children's Hospital, Boston, USA
DNA repair and mutations as targets for personalised therapy ( Prof Zoltan Szallasi - Boston Children's Hospital, Boston, USA )
15 Jul 2016
The changing process of drug discovery and design
Dr Ian Waddell - Cancer Research UK Manchester Institute, Manchester, UK
The changing process of drug discovery and design ( Dr Ian Waddell - Cancer Research UK Manchester Institute, Manchester, UK )
14 Jul 2016
Glioblastoma heterogeneity in circulating tumour DNA
Dr Joan Seoane - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Glioblastoma heterogeneity in circulating tumour DNA ( Dr Joan Seoane - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
14 Jul 2016
Obesity promotes pancreatic cancer progression and resistance
Dr Joao Incio - Massachusetts General Hospital, Boston, USA
Obesity promotes pancreatic cancer progression and resistance ( Dr Joao Incio - Massachusetts General Hospital, Boston, USA )
14 Jul 2016
Connections in cancer-host immune signalling
Dr Alan Serrels - University of Edinburgh, Edinburgh, UK
Connections in cancer-host immune signalling ( Dr Alan Serrels - University of Edinburgh, Edinburgh, UK )
14 Jul 2016
Targeting and imaging invasion and metastasis
Prof Margaret Frame - Edinburgh Cancer Research Centre, Edinburgh, UK
Targeting and imaging invasion and metastasis ( Prof Margaret Frame - Edinburgh Cancer Research Centre, Edinburgh, UK )
14 Jul 2016
ERß expression predicts breast cancer risk in hyperplasia
Dr Tina Hieken - Mayo Clinic, Rochester, USA
ERß expression predicts breast cancer risk in hyperplasia ( Dr Tina Hieken - Mayo Clinic, Rochester, USA )
14 Jul 2016
Advances in early detection
Prof Paul Pharoah - University of Cambridge, Cambridge, UK
Advances in early detection ( Prof Paul Pharoah - University of Cambridge, Cambridge, UK )
13 Jul 2016
Polygenic risk and the targeted prevention of cancer
Prof Paul Pharoah - University of Cambridge, Cambridge, UK
Polygenic risk and the targeted prevention of cancer ( Prof Paul Pharoah - University of Cambridge, Cambridge, UK )
13 Jul 2016
Regulation of T cells in tissues and tumours
Prof Adrian Hayday - King's College London, London, UK
Regulation of T cells in tissues and tumours ( Prof Adrian Hayday - King's College London, London, UK )
13 Jul 2016
Physical pressure of tumour on healthy cells induces oncogenes
Dr Emmanuel Farge - Institut Curie, Paris, France
Physical pressure of tumour on healthy cells induces oncogenes ( Dr Emmanuel Farge - Institut Curie, Paris, France )
13 Jul 2016
Understanding mutational processes in human cancer
Dr Ludmil Alexandrov - Los Alamos National Laboratory, Los Alamos, New Mexico
Understanding mutational processes in human cancer ( Dr Ludmil Alexandrov - Los Alamos National Laboratory, Los Alamos, New Mexico )
13 Jul 2016
ß1 integrins and DNA repair for radiosensitization of head and neck cancer
Dr Nils Cordes - Center for Radiation Research in Oncology, Dresden, Germany
ß1 integrins and DNA repair for radiosensitization of head and neck cancer ( Dr Nils Cordes - Center for Radiation Research in Oncology, Dresden, Germany )
13 Jul 2016
Mouse models of lung cancer
Dr Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands
Mouse models of lung cancer ( Dr Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands )
13 Jul 2016
'Rewiring' tumour susceptibility
Dr Michael Yaffe - MIT, Cambridge, USA
'Rewiring' tumour susceptibility ( Dr Michael Yaffe - MIT, Cambridge, USA )
13 Jul 2016
Deciphering RAS/MAPK signalling in cancer
Dr Mariano Barbacid - CNIO, Madrid, Spain
Deciphering RAS/MAPK signalling in cancer ( Dr Mariano Barbacid - CNIO, Madrid, Spain )
13 Jul 2016